Insider trades

Peter A. Thompson, Director of ARS Pharmaceuticals SPRY, has filed 5 purchases and 30 sales on the open market. Over the past 12 months that comes to a net sale of $46.5M. The latest trade was on 06/24.

Peter A. Thompson

Director
First filing
23/01/05
Trades
96 trades
Buys / sales
5 / 30
12-month net buying
−$46.5M
Last trade
06/24

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan05/2705/29101 sh$44.49$4,493.49−0.0%
SION
Open-market sale10b5-1 plan05/07–05/1105/11292,952 sh3 trades$45.62avg.$13,364,064.5−9.9%
SION
Open-market sale10b5-1 plan04/17–04/1804/2155,345 sh2 trades$44.67avg.$2,472,342.92−1.8%
SION
Open-market sale10b5-1 plan04/14–04/1604/16510,583 sh3 trades$44.94avg.$22,945,043.5−14.5%
SION
Open-market sale10b5-1 plan02/02–02/0302/0430,953 sh2 trades$44.58avg.$1,379,865.84−0.9%
Open-market sale10b5-1 plan25/12/2425/12/2933,356 sh$44.55$1,486,009.8−0.9%
SION
Open-market sale10b5-1 plan25/12/17–25/12/1925/12/191,875 sh3 trades$44.49avg.$83,427.75−0.1%
SION
Open-market sale10b5-1 plan25/11/24–25/11/2625/11/26108,073 sh3 trades$44.55avg.$4,814,204.82−2.9%
Open-market sale25/06/2725/07/011,176,332 sh$4.16$4,893,541.12−14.1%
EWTX
Open-market buy25/04/0325/04/04496,771 sh2 trades$20.13avg.$10,000,000.23No record
Open-market buy25/02/1025/02/10550,000 sh$18.00$9,900,000+17.4%
Open-market sale24/08/2624/08/2883,695 sh$13.00$1,088,035−100.0%
SPRY
Open-market sale24/08/21–24/08/2324/08/23868,682 sh4 trades$13.24avg.$11,497,963.08−91.2%
Open-market buy24/01/2324/01/25454,545 sh$11.00$4,999,995+3.3%
Open-market sale23/12/27–23/12/2823/12/291,546,347 sh6 trades$18.54avg.$28,671,733.76−85.4%
Open-market buy23/08/2923/08/31500,000 sh$6.20$3,100,000+6.6%